Zioptan and Fainting - a phase IV clinical study of FDA data

Summary:

Fainting is reported as a side effect among people who take Zioptan (tafluprost), especially for people who are female, 60+ old, also take Calcium, and have Blood pressure abnormal.

The phase IV clinical study analyzes which people have Fainting when taking Zioptan. It is created by eHealthMe based on reports of 2,491 people who have side effects when taking Zioptan from the FDA, and is updated regularly.

What is Zioptan?

Zioptan has active ingredients of tafluprost. It is often used in glaucoma. eHealthMe is studying from 2,512 Zioptan users. Check the latest studies of Zioptan.

What is Fainting?

Fainting (loss of consciousness and postural tone) is found to be associated with 2,457 drugs and 3,547 conditions by eHealthMe. Check the latest studies of Fainting.

On Jul, 16, 2026

2,491 people reported to have side effects when taking Zioptan.
Among them, 17 people (0.68%) have Fainting.

Among these 17 people:

What is the gender of people who have Fainting when taking Zioptan? *

female: 88.24 %
male: 11.76 %

What is the age of people who have Fainting when taking Zioptan? *

What are other drugs people take besides Zioptan? *

What are other side effects people have besides Fainting? *

Weakness: 8 people, 47.06%
Dyspnea (difficult or laboured breathing): 8 people, 47.06%
Nausea And Vomiting: 8 people, 47.06%
Malnutrition (a condition that results from eating a diet in which certain nutrients are lacking): 8 people, 47.06%
Malaise (a feeling of general discomfort or uneasiness): 8 people, 47.06%
Lung Disorder (lung disease): 8 people, 47.06%
Hernia (hernia happens when part of an internal organ or tissue bulges through a weak area of muscle): 8 people, 47.06%
Fungal Infection: 8 people, 47.06%
Feeding Disorder (when children refuse to eat certain food groups): 8 people, 47.06%
Emphysema (chronic respiratory disease - over inflation of the air sacs (alveoli) in the lungs): 8 people, 47.06%

What are the existing conditions these people have? *

Blood Pressure Abnormal: 10 people, 58.82%
Thyroid Diseases: 9 people, 52.94%
High Blood Pressure: 9 people, 52.94%
Ill-Defined Disorder: 8 people, 47.06%
Lung Disorder (lung disease): 8 people, 47.06%
Constipation: 8 people, 47.06%
Diabetes: 8 people, 47.06%
Emphysema (chronic respiratory disease - over inflation of the air sacs (alveoli) in the lungs): 8 people, 47.06%
Feeling Of Relaxation: 8 people, 47.06%
Glossitis (infection of tongue with soreness): 8 people, 47.06%

* Approximation only. Some reports may have incomplete information.

Do you take Zioptan and have Fainting?

- Check whether Fainting is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Zioptan:

Zioptan (2,512 reports)

Fainting treatments and more:

Fainting (131,321 reports)

Browse all side effects of Zioptan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Fainting:

Fainting (2,457 drugs)

Browse all the conditions that are associated with Fainting:

Fainting (3,547 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on tafluprost (the active ingredients of Zioptan) and Zioptan (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.